Ansley Kelm
Showing of 170 results
Former British Prime Minister David Cameron, Medical Leaders and Researchers from around the World Convene in Cleveland to Discuss Drug Development Progress
Harrington Discovery Institute at University Hospitals Holds 12th Annual Scientific Symposium
Potential New Treatment for Alzheimer's Disease, Other Neurodegenerative Conditions
Drug developed by Case Western Reserve, UH and Cleveland VA researchers found to protect ‘guardian of the brain’
May is American Stroke Month: University Hospitals Offering Free Screenings and Educational Events
University Hospitals Neurological Institute is offering the community peace of mind with free stroke screenings, educational events and health talks with neurologists.
Oxford-Harrington Rare Disease Centre Appoints Majid Jafar to its Advisory Council
Mr. Jafar is a distinguished international business leader and co-founder of the Loulou Foundation.
UH Cleveland Medical Center Currently Recruiting People with Early Alzheimer’s Disease for a Clinical Trial Evaluating Benfotiamine, a Synthetic Version of Thiamine (Vitamin B1)
Phase 2 study funded by the National Institute on Aging, part of the NIH, is evaluating effects of benfotiamine on cognitive function.
Dr. Cliff Megerian Represents University Hospitals at U.S. Health and Human Services Roundtable
UH CEO is one of four healthcare CEOs from across the country invited to participate in defining hospitals’ role in Making America Healthy Again and additional key priorities.
Harrington Discovery Institute Opens Call for 2026 Harrington Scholar-Innovator Award
Unique program for physician-scientists to advance promising discoveries into medicines.
University Hospitals Receives American Organization for Nursing Leadership Prism Award
Health system recognized for exceptional commitment to recruiting, retaining, and developing nursing talent.